United States

People: Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

15 Feb 2019
Change (% chg)

$0.15 (+3.02%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Callicutt, Jack 

Mr. Jack W. Callicutt is Chief Financial Officer, Company Secretary effective on June 8, 2018. From August 2012 through June 2012, Mr. Callicutt was the Chief Financial Officer of REACH Health, Inc., a telemedicine technology company headquartered in Alpharetta, GA. From April 2010 through August 2012, Mr. Callicutt was the Chief Financial Officer of Vystar Corporation, a publicly-traded company that holds proprietary technology to remove antigenic proteins from natural rubber latex. Prior to that Mr. Callicutt was Chief Financial Officer of IVOX, Inc., Tikvah Therapeutics and Corautus Genetics, a publicly-traded biotechnology company which was developing gene therapy for treatment of cardiovascular disease. Mr. Callicutt previously spent more than fourteen years in public accounting, most recently as a senior manager at Deloitte, where he specialized in technology companies from 1989 to 2003. Mr. Callicutt is a Certified Public Accountant and graduated with honors from Delta State University with a B.B.A. in accounting and computer information systems.

Basic Compensation

Total Annual Compensation, USD 351,163
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 54,848
Fiscal Year Total, USD 406,011

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --